Barely Significant
← all excerpts

Anti-TNF-alpha treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial.

Hum Reprod · 2008 · PMC2517154 · PMID 18556683

Europe PMCDOI
1
hedged sentence
0.0030
closest p · 0.1× alpha
0.0030
boldest claim

The sentences

highly significantP < 0.003actually significant
The placebo effect was not significant for the early treatment period (Visits 3 and 4) but highly significant for the late treatment period (Visits 5 and 6) both by two way analysis of variance ( P < 0.003 to 0.001 for all) and when the placebo (Wilcoxon, P < 0.001) and the infliximab group (Wilcoxon, P < 0.001) were analysed separately.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.